Source: Virtual Congress 2020 – Challenges and updates in nursing care around the world
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
W. Giron Matute (Madrid, Spain), M. Hernandez Yañez (Madrid, Spain), R. Rojas Moreno-Tomé (Madrid, Spain), M. Gallardo Bermejo (Madrid, Spain), A. Gómez Sacristán (Madrid, Spain), B. Escalonilla Bautista (Madrid, Spain), M. Suarez Rubio (Madrid, Spain), J. García López (Madrid, Spain), L. Puente Maestu (Madrid, Spain). Alpha 1 antitrypsin deficiency prevalence measured by genetic testing with salivary swab in patients with chronic airway obstruction. 585

Member's Comments

No comment yet.

Related content which might interest you: Prevalence of mutations in the alpha 1 antitrypsin gene in patients with pulmonary emphysema Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions Year: 2019 Dupilumab reduces blood and nasal biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps with and without comorbid asthma: SINUS-52 trial Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020 Use of measurements of airway resistance in the determination of reversibility in patients with emphysema associated with alpha-1-antitrypsin (A1ATD) deficiency Source: Eur Respir J 2001; 18: Suppl. 33, 205s Year: 2001 Screening for α1-Pi deficiency in patients with lung diseases Source: Eur Respir J 2002; 20: 319-324 Year: 2002 Functional alterations of small airways in patients with alpha-1 antitrypsin deficiency (AATD) in a longitudinal study Source: Eur Respir J 2005; 26: Suppl. 49, 361s Year: 2005 Prevalence of alpha1-antitrypsin deficiency and its influence on lung function decline in patients with severe asthma Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Impact of bronchial airflow limitation and recent respiratory tract infection on the circulating level of C-reactive protein in an elderly population Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia Year: 2006 Specific airway resistance as a marker of early disease in alpha-1 antitrypsin deficiency Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system Year: 2015 Prevalence of coexistent airways obstruction in patients with cardiac disease Source: Eur Respir J 2004; 24: Suppl. 48, 278s Year: 2004 Alpha-1 antitrypsin deficiency in patients with COPD/emphysema, bronchiectasis and asthma Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases Year: 2020 Clinically in-apparent chlamydia infections are associated with chronic obstruction and persistent inflammation of peripheral airways (animal model) Source: Eur Respir J 2006; 28: Suppl. 50, 575s Year: 2006 Laboratory testing of individuals with severe α1-antitrypsin deficiency in three European centres Source: Eur Respir J 2010; 35: 960-968 Year: 2010 Airway obstruction findings in the lung function testing: prevalence and determinants Source: Eur Respir J 2004; 24: Suppl. 48, 361s Year: 2004 The association between serum osmolality and lung function among adults Source: Eur Respir J 2008; 32: 98-104 Year: 2008 Pattern of bronchial colonization and inflammatory response in patients with bronchiectasis and immunoglobulin deficiency (Igdef) Source: Eur Respir J 2001; 18: Suppl. 33, 466s Year: 2001 The impact of different spirometric definitions on the prevalence of airway obstruction and their association with respiratory symptoms Source: ERJ Open Res, 3 (4) 00110-2017; 10.1183/23120541.00110-2017 Year: 2017 Endobronchial valve treatment in patients with severe emphysema due to alpha-1 antitrypsin deficiency. Source: International Congress 2019 – Interventional pulmonology: diagnostic techniques and obstructive airway disease Year: 2019 Plasma surfactant protein A levels are increased in smokers but do not correlate with respiratory symptoms and airway obstruction Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010 Estimating the prevalence of undiagnosed inducible laryngeal obstruction within a severe asthma cohort Source: Virtual Congress 2021 – Lung disease burden and management Year: 2021 Reduction in incidence of exacerbations in patients with alpha 1 antitrypsin deficiency (A1ATD) treated with concentrates of alpha 1 antitrypsin (A1AT): REXA study Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011